Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page
- Check7 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating a new revision or update to the page content.SummaryDifference0.1%

- Check14 days agoChange DetectedFooter now shows Revision: v3.6.2, indicating an updated page revision. No trial data, eligibility criteria, or contact information were changed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusted the Intervention/Treatment label formatting; also updated the site revision tag from v3.5.5 to v3.6.0.SummaryDifference1%

- Check35 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the page or its metadata.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, representing an internal update or patch to the page rather than a change to the study data. This indicates maintenance or bug fixes without altering study details.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a site/version change rather than any change to the clinical trial details.SummaryDifference0.1%

Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.